IOP Injection

DRUG2 trials

Sponsors

MegaPro Biomedical Co. Ltd.

Conditions

Magnetic Resonance Imaging

Phase 1

Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects

CompletedNCT02744248

MegaPro Biomedical Co. Ltd.Magnetic Resonance Imaging

Start: 2016-02-29End: 2017-12-31Updated: 2018-08-17

Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects

CompletedNCT03399214

MegaPro Biomedical Co. Ltd.Magnetic Resonance Imaging

Start: 2018-04-01End: 2018-07-31Updated: 2018-08-17